Prostate

Urology Hospital Pretoria among first in SA to offer latest technology in BPH – Hope to SA men

Worldwide approx. 50% of men aged 51-60 and up and 70% of men aged 60-69 have Benign Prostate Hyperplasia (BPH), reveals Yale Medicine research. In SA, an estimated 50% of men aged 60 have symptomatic BPH with an annual increase in the number of black men affected.  This condition, of prostate gland enlargement, affects 94 […]

Urology Hospital Pretoria among first in SA to offer latest technology in BPH – Hope to SA men Read More »

Prostate Cancer: Shortened radiation therapy for high-risk patients confirmed safe

A new randomized study confirms that men with high-risk prostate cancer can be treated with five versus eight weeks of radiation therapy. The phase III clinical trial is the first to confirm the safety and efficacy of a moderately shortened course of radiation exclusively for patients with high-risk disease. Findings from the Prostate Cancer Study

Prostate Cancer: Shortened radiation therapy for high-risk patients confirmed safe Read More »

Prostate Cancer: More intensive screening may reduce metastatic cancer

In the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a large, longitudinal analysis found Veterans Health Administration (VA) medical centers with lower prostate screening rates had higher rates of metastatic prostate cancer cases in subsequent years than centers with higher screening rates. Findings of the study will be

Prostate Cancer: More intensive screening may reduce metastatic cancer Read More »

Prostate Cancer: Combination treatment for patients with oligometastatic

A new study offers a new option to patients with oligometastatic prostate cancer who want relief from hormone therapy without compromising the risk of their disease spreading. In the study, patients who received radiation in addition to intermittent hormone therapy lived longer without their disease progressing, and they were able to take longer breaks from

Prostate Cancer: Combination treatment for patients with oligometastatic Read More »

Prostate Cancer: New therapeutic approach against treatment-resistance

Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in the peer-reviewed journal Molecular Therapy, have led to a larger, multicenter trial that will soon be underway. Cancer of the prostate, a small gland just below the bladder,

Prostate Cancer: New therapeutic approach against treatment-resistance Read More »

Take the test for Prostate Cancer Awareness month

This September, Prostate Cancer Awareness month, The Urology Hospital will participate in the “I took the Test” campaign in partnership with Astellas and The Prostate Cancer Foundation by providing free PSA tests. Prostate cancer is the most common cancer affecting men in SA and showing significant increases. The lifetime risk for prostate cancer in men in

Take the test for Prostate Cancer Awareness month Read More »

Prostate cancer patients benefit from precision oncology

Researchers at the University of Bern and University Hospital Bern have achieved a breakthrough in a particularly aggressive form of prostate cancer. In tissue samples from advanced brain metastases, they were able to establish the genetic profile of the cancer cells. These findings show for the first time that affected patients could benefit from target

Prostate cancer patients benefit from precision oncology Read More »

Manage prostate cancer with High-intensity focused ultrasound

High-intensity focused ultrasound

In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate cancer considered to be “intermediate risk” — mostly, small tumors confined to one area of the prostate. At Memorial Sloan Kettering Cancer Center (MSK), researchers have been working closely with an advanced focal therapy approach known as

Manage prostate cancer with High-intensity focused ultrasound Read More »

Regular prostate cancer screening cancels out aggressive cases

Regular prostate cancer screening cancels out aggressive cases

Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate cancer. Now, researchers from Weill Cornell Medicine have found that while these efforts have been effective, the incidence of higher-grade disease and metastasis

Regular prostate cancer screening cancels out aggressive cases Read More »

Appointments